Diabetes care cascade and their predictors in young and middle-aged population in India: evidence from the National Family Health Survey (2019-21)

Saurav Basu; Vansh Maheshwari; Mansi Malik; Paras Agarwal

doi:10.1007/s40200-023-01263-9

Diabetes care cascade and their predictors in young and middle-aged population in India: evidence from the National Family Health Survey (2019-21)

J Diabetes Metab Disord. 2023 Jul 24;22(2):1405-1415. doi: 10.1007/s40200-023-01263-9. eCollection 2023 Dec.

Authors

Saurav Basu¹, Vansh Maheshwari¹, Mansi Malik¹, Paras Agarwal²

Affiliations

¹ Indian Institute of Public Health - Delhi, Public Health Foundation of India, Plot No 47, Institutional Area, Sector 44, Gurugram, 122002 Haryana India.
² Max Healthcare, Max Multi Speciality Centre, Panchsheel Park, New Delhi India.

PMID: 37975129
PMCID: PMC10638169 (available on 2024-07-24)
DOI: 10.1007/s40200-023-01263-9

Abstract

Purpose: Weak care cascade of diabetes from the time of screening, diagnosis, treatment initiation and attainment of optimal glycemic control is a public health challenge particularly in resource limited settings. We aimed to assess the diabetes care cascade in India and its determinants in the 15-49 age group.

Methods: We conducted a secondary data analysis of the National Family Health Survey (NFHS-5, 2019-2021), a nationally representative cross-sectional survey, including a total of 724,115 women and 101,839 men with mean (SD) age 30.6 (9.9) years.

Results: The prevalence of self-reported Diabetes Mellitus (DM) in the sample was 2.14% (n = 14,116, 95% CI: 2.06, 2.21) of which 55.13% (n = 6990, 95% CI: 53.37, 56.88) were currently undergoing anti-diabetes therapy. The net prevalence of DM including both old and new cases detected on screening was 2.9%. Poor glycemic control was observed in 52.43% (n = 3506, 95% CI: 50.69, 54.16) of patients with DM on anti-diabetes therapy. Patients from the richest wealth quintile (aOR = 5.17, 95% CI: 1.93, 13.84) had significantly higher odds of accessing private health facilities, while female patients with DM were less likely to be on anti-diabetes therapy.

Conclusion: The prevalence of self-reported DM in India has increased from 1.7% (NFHS-4, 2015-16) to 2.1% (NFHS-5, 2019-21) while more than half of existing patients continue to remain undiagnosed. Consequently, diabetes care cascade have major lacunae at every stage from screening to diagnosis, initiation of effective treatment, and achievement of safe blood glucose levels.

Supplementary information: The online version contains supplementary material available at 10.1007/s40200-023-01263-9.

Keywords: Care cascade; Diabetes Mellitus; Glycemic control; NFHS-5.

© The Author(s), under exclusive licence to Tehran University of Medical Sciences 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.